Making Pig-to-Human Transplantation a Clinical Reality | Luhan Yang

Tuesday, January 07, 2020

Making Pig-to-Human Transplantation a Clinical Reality | Luhan Yang || Radcliffe Institute

Xenotransplantation is a promising strategy for addressing the shortage of organs for human transplantation. Using CRISPR-Cas9, Luhan Yang, the cofounder and CEO of QihanBio, has helped create a genome editing platform that addresses many of the concerns over pig-to-human immunological compatibility and the risk of cross-species transmission of porcine endogenous retroviruses (PERVs). Join Yang as she shares her mission to create a new world in which no patient has to die while waiting for an organ transplant.

This event is part of the Gene Editing Science Lecture Series and the Unknown and Solitary Seas Gallery Series at the Radcliffe Institute for Advanced Study, Harvard University.